<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Bucindolol</id>
	<title>Bucindolol - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Bucindolol"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Bucindolol&amp;action=history"/>
	<updated>2026-04-25T05:00:57Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Bucindolol&amp;diff=5368232&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Bucindolol&amp;diff=5368232&amp;oldid=prev"/>
		<updated>2024-03-06T03:39:37Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Bucindolol.png|thumb|{{PAGENAME}}]]&amp;lt;br&amp;gt;&amp;#039;&amp;#039;&amp;#039;Bucindolol&amp;#039;&amp;#039;&amp;#039; is a [[non-selective beta blocker]] and [[beta-1 adrenergic receptor]] antagonist that was developed to treat [[hypertension]] and [[heart failure]]. It is unique among beta blockers for its additional properties as a [[beta-2 adrenergic receptor]] antagonist and [[alpha-1 adrenergic receptor]] antagonist. &lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
Bucindolol is a [[beta blocker]], a class of drugs that work by blocking the action of [[epinephrine]] (adrenaline) on the [[beta receptors]] in the heart and blood vessels. This slows the heart rate and reduces the force of heart contractions, which lowers blood pressure and reduces the heart&amp;#039;s demand for oxygen. Bucindolol is non-selective, meaning it blocks both beta-1 and beta-2 receptors. &lt;br /&gt;
&lt;br /&gt;
In addition to its beta-blocking activity, Bucindolol also has mild [[vasodilating]] properties due to its antagonism of alpha-1 adrenergic receptors. This can help to further lower blood pressure.&lt;br /&gt;
&lt;br /&gt;
==Clinical Use==&lt;br /&gt;
Bucindolol was developed for the treatment of [[hypertension]] (high blood pressure) and [[heart failure]]. In heart failure, it works by reducing the heart&amp;#039;s workload and helping the heart to pump more efficiently. In hypertension, it helps to lower blood pressure by reducing the force and rate of heart contractions.&lt;br /&gt;
&lt;br /&gt;
==Side Effects==&lt;br /&gt;
Like all medications, Bucindolol can cause side effects. Common side effects include [[bradycardia]] (slow heart rate), [[hypotension]] (low blood pressure), [[fatigue]], and [[dizziness]]. Less common side effects can include [[depression]], [[insomnia]], and [[shortness of breath]].&lt;br /&gt;
&lt;br /&gt;
==Development and Approval==&lt;br /&gt;
Bucindolol was developed by a pharmaceutical company called [[Bristol-Myers Squibb]]. However, it was not approved by the [[Food and Drug Administration]] (FDA) in the United States due to concerns about its side effect profile. Despite this, it has been approved for use in other countries.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[Beta blocker]]&lt;br /&gt;
* [[Hypertension]]&lt;br /&gt;
* [[Heart failure]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
[[Category:Beta blockers]]&lt;br /&gt;
[[Category:Drugs]]&lt;br /&gt;
{{Pharmacology-stub}}&lt;br /&gt;
{{Beta-blockers}}&lt;br /&gt;
{{Cardiac drugs}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>